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Abstract 33 
 34 
Background: Preterm birth (PTB) and small for gestational age (SGA) are increasingly 35 
prevalent, with major consequences for health and development into later life. There is 36 
emerging evidence that some risk processes begin before pregnancy. We report on 37 
associations between maternal and paternal common mental disorders (CMD) before and 38 
during pregnancy and offspring PTB and SGA. 39 
 40 
Methods: 398 women with 609 infants and 267 men with 421 infants were assessed 41 
repeatedly for CMD symptoms before pregnancy between age 14 and 29 and during 42 
pregnancy. Associations between preconception and antenatal CMD symptoms and 43 
offspring gestational age/PTB and size for gestational age/SGA were estimated using linear 44 
and Poisson regression. 45 
  46 
Findings: In men, persistent preconception CMD across adolescence and young adulthood 47 
predicted offspring PTB after adjustment for ethnicity, education, BMI and adolescent 48 
substance use (adjusted RR 7·0, 95% CI 1·8,26·8), corresponding to a population 49 
attributable fraction of 31% of preterm births. In women, antenatal CMD symptoms 50 
predicted offspring PTB (adjusted RR 4·4, 95% CI 1·4,14·1). There was little evidence of 51 
associations with SGA.  52 
  53 
Interpretation: This first report of an association between paternal preconception mental 54 
health and offspring gestational age, while requiring replication in larger samples, 55 
complements earlier work on stress in animals, and further strengthens the case for 56 
expanding preconception mental health care to both men and women. 57 
 58 
Funding: National Health and Medical Research Council (Australia), Victorian Health 59 
Promotion Foundation, Australian Rotary Health, Colonial Foundation, Perpetual Trustees, 60 
Financial Markets Foundation for Children (Australia), Royal Children’s Hospital 61 
Foundation, Murdoch Children’s Research Institute, Australian Research Council.   62 
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Research in context 63 
 64 
Evidence before this study 65 
Consistent evidence links maternal antenatal symptoms of common mental disorders 66 
(CMD) with offspring preterm birth and small for gestational age. Although findings from 67 
animal studies implicate both maternal and paternal preconception stress in offspring birth 68 
outcomes, the extent to which maternal and paternal history of preconception CMD predict 69 
offspring preterm birth and small for gestational age in humans is unknown.  70 
 71 
Added value of this study 72 
In this population-based preconception cohort study, we prospectively assessed maternal 73 
and paternal CMD over 15 years from adolescence to young adulthood and in the third 74 
trimester of subsequent pregnancies. Our findings that up to 31% of preterm births may be 75 
attributable to processes relating to persistent preconception CMD symptoms in men 76 
heralds a paradigm shift for the developmental origins of health and disease. It highlights a 77 
need to further explore paternal CMD and other preconception risk factors as determinants 78 
of early life health, growth and development.   79 
 80 
Implications of all the available evidence  81 
Paternal mental health represents a neglected and potentially novel risk factor for preterm 82 
birth. While they require replication in other populations and a greater understanding of 83 
potential mechanisms, our findings support expansion of the focus of preconception care to 84 
include both men and women. Therefore new and potentially innovative approaches to 85 
preconception interventions will be necessary to optimise the health of future generations. 86 
  87 
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Introduction 88 
 89 
Preterm birth (PTB) and small for gestational age (SGA) are leading causes of neonatal 90 
morbidity and mortality. 1 Early and mid-late PTB carry lifelong effects on health and 91 
development. 2  SGA is also associated with increased risk for neonatal morbidity and 92 
mortality, as well as short- and long-term adverse health outcomes and functional 93 
impairment, with these effects attributable primarily to fetal growth restriction. 3 94 
Considerable research has focussed on antenatal risk factors for these adverse birth 95 
outcomes 4 but these only explain a small proportion of variance in PTB and SGA and 96 
preventive intervention efforts based on these risk factors are estimated to reduce PTB rates 97 
by only 5%. 5 For these reasons, understanding drivers of PTB and SGA remains a priority 98 
in public health policy and practice. 99 
 100 
One explanation may be that some risks emerge well before pregnancy. 6 Maternal and 101 
paternal preconception exposures, including obesity, substance use, and education all 102 
predict patterns of offspring development. 7 In experimental animal research, parental 103 
preconception stress has been linked to offspring development via enduring effects on 104 
parental reproductive biology. 8 These findings point to an influence of preconception stress 105 
on offspring development even in the absence of antenatal exposure. There is some 106 
suggestion in humans that links between antenatal maternal mental disorder and offspring 107 
PTB may originate in the years immediately prior to pregnancy. 9 Associations between 108 
paternal preconception mental disorder and offspring later life mortality have been 109 
identified, 10 but links to early offspring development, including birth outcomes, remain 110 
largely unstudied.  111 
 112 
Mental health problems commonly become prominent in adolescence, persisting into 113 
adulthood and the transition to parenthood. 11,12 Investigating contributions of mental health 114 
problems, from adolescence to parenthood, to offspring birth outcomes may help elucidate 115 
mechanisms and identify possible intervention points. For example, the timing and 116 
persistence of any effects may implicate either sensitive periods or chronicity. Effects of 117 
exposure before, but not during, pregnancy may indicate direct preconception effects on 118 
parental reproductive biology, or mediation through other antenatal pathways. 13 Effects of 119 
parental mental disorder both before and during pregnancy may suggest effects of exposure 120 
at each phase via differing mechanisms, or confounding by underlying genetic or 121 
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environmental influences of the association between mental disorder and offspring PTB or 122 
SGA. 14 Comparison of maternal and paternal associations is a further approach to 123 
investigating confounding effects of shared genes and environment, under the assumption 124 
that maternal and paternal exposures are similarly confounded. 15 For example, effects of 125 
maternal but not paternal symptoms may suggest a direct intrauterine effect rather than 126 
familial confounding. 15,16  127 
 128 
Here, we used a two-generation cohort study with prospective data on maternal and paternal 129 
mental disorder over 15 years from adolescence to young adulthood, and again during 130 
pregnancy. We aimed to examine the association between maternal and paternal symptoms 131 
of common mental disorders (CMD) from adolescence to parenthood and offspring birth 132 
outcomes of PTB or SGA and whether these associations differ by timing of parental CMD 133 
symptoms and parent exposed.  134 
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Methods 135 
 136 
Sample 137 
 138 
The Victorian Intergenerational Health Cohort Study (VIHCS) is an ongoing prospective 139 
intergenerational study of preconception predictors of infant and child health, described 140 
elsewhere. 17 It arose from a cohort study commencing in 1992 in the state of Victoria, 141 
Australia (The Victorian Adolescent Health Cohort Study; VAHCS). 18 Briefly, a 142 
representative sample of 1943 Victorian mid-secondary school students (1000 female) were 143 
selected via a two-stage cluster sampling design and assessed six-monthly during 144 
adolescence (VAHCS Waves 1-6: mean ages 14·9-17·4 years), and three times in young 145 
adulthood (VAHCS Waves 7-9: 20·7, 24·1 and 29·1 years). VIHCS began in 2006 during 146 
the ninth wave of VAHCS. Between 2006 and 2013 (participant age 29-35 years, 147 
encompassing median maternal and paternal ages for Australian births (Australian Bureau 148 
of Statistics, 2013)), VAHCS participants were screened at six-monthly intervals for 149 
pregnancies via SMS, email, and phone. Participants reporting a pregnancy or recently born 150 
infant were invited to participate in VIHCS, and asked to complete telephone interviews in 151 
trimester three, two months’ postpartum and one year postpartum for each infant born 152 
during VIHCS screening. Participants’ parents or guardians provided informed written 153 
consent at recruitment into VAHCS, and participants and their partners who participated 154 
provided informed verbal consent at subsequent waves.  155 
 156 
Measures 157 
Exposures 158 
Preconception common mental disorder (CMD) symptoms were assessed during VAHCS 159 
Waves 2-7 (participant ages 14-21 years) using the Revised Clinical Interview Schedule 160 
(CIS-R), 19 a structured psychiatric interview designed to assess symptoms of anxiety and 161 
depression in community samples. The CIS-R has been validated for use with adolescent 162 
populations. 20 At each wave, total score was dichotomised at ≥12 to identify mixed 163 
depression-anxiety symptoms at a level lower than major depressive or anxiety disorder, but 164 
which a general practitioner would view as clinically significant. 19 At Waves 8 and 9 165 
(participant ages 24 and 29), symptoms of psychological distress were assessed with the 12-166 
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item General Health Questionnaire (GHQ-12), a screening measure widely used to assess 167 
psychiatric illness in the general population. Total scores were dichotomised at ≥3, a 168 
threshold that indicates psychological distress with sensitivity 76% and specificity 83%, 21,22 169 
and corresponds to a CIS-R threshold of ≥12. 19 In Wave 9, the Composite International 170 
Diagnostic Interview (CIDI) was used to assess depression (CIDI auto) 23 and anxiety (CIDI 171 
short form). 24 Major depressive disorder and anxiety disorder were defined according to 172 
International Classification of Diseases, 10th revision (ICD-10). We constructed variables 173 
denoting presence of CMD symptoms at ≥1 adolescent wave (VAHCS Waves 2-6), and ≥1 174 
young adult wave (VAHCS Waves 7-9). Continuity of CMD symptoms from adolescence 175 
to adulthood was defined as ‘none’, ‘adolescent only’, ‘young adult only’, and ‘both 176 
adolescent and young adult’. 177 
 178 
Antenatal CMD symptoms were assessed in trimester three of pregnancy. Women were 179 
assessed using the Edinburgh Postnatal Depression Scale (EPDS). 25 The EPDS is a 10-item 180 
rating scale designed to screen for postpartum depression and validated for antenatal use. 26 181 
The total score (range 0-30) at each wave was dichotomised at a threshold (≥10) that is 182 
appropriate for use in community samples and when administered via telephone. 27,28 This 183 
cut-off has been recommended for use in detecting mild to severe postnatal depression, with 184 
a recent meta-analytic estimates of 95% sensitivity and 82% specificity in detecting major 185 
depressive disorder in the postpartum. 29 Men completed the General Health Questionnaire 186 
(GHQ-12), which was dichotomised at ≥3 as per the preconception young adult waves. 19 187 
 188 
Outcomes 189 
Offspring sex, gestational age at birth, and birthweight were maternally reported (by 190 
VAHCS cohort participant or, for male VAHCS participants, by their partner) either at the 191 
first postpartum assessment at two months postpartum (86% of participants), at one year 192 
postpartum (3%), or during VAHCS wave 10 (11%; mean child age at assessment 3·8 193 
years, SD = 1·9 years). 30 Gestational age at birth was reported in completed weeks and 194 
categorised as preterm (PTB: <37 weeks’ gestation) and term (≥37 weeks’ gestation). Size 195 
for gestational age was calculated as birthweight z-scores, relative to the British Growth 196 
Reference. 31,32 These population norms provide expected distributions of birth weight 197 
according to gestational age and sex of infant. Small for gestational age (SGA) was defined 198 
as <10th percentile (birthweight z-score <1·28).  199 
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 200 
Confounders  201 
Our conceptual model included factors that were potential confounders of the associations 202 
between parental CMD symptoms and infant birth outcomes, excluding those potentially on 203 
the causal pathway from exposure to outcome. 33 Family of origin sociodemographic 204 
characteristics were: participants’ parents’ high school completion (neither v. at least one 205 
parent completed high school) and participants’ ethnicity (3-generation European descent). 206 
Measures of participant substance use at baseline in adolescence were: daily cigarette 207 
smoking (daily cigarette smoking at one or more waves v. no daily smoking), and binge 208 
drinking (ever v. never drank >5 drinks in a drinking occasion in the past week). Body mass 209 
index (BMI) was also considered as two binary variables of overweight (BMI ≥25 at any 210 
adolescent wave v. not overweight) and underweight (BMI <18.5 at any adolescent wave v. 211 
not underweight).  212 
 213 
Statistical analysis 214 
 215 
Data were analysed separately for women and men using Stata version 15. 34 Multivariable 216 
robust Poisson and linear regression were employed for binary and continuous outcomes 217 
respectively, within a generalised estimating equation framework with robust standard 218 
errors, in particular to account for family clustering where more than one pregnancy per 219 
participant were included. The distribution of continuous outcomes was assessed for women 220 
and men using histograms stratified by exposure category, with the approximate symmetry 221 
deeming modelling of the mean via linear regression appropriate. Models were adjusted for 222 
parental ethnicity, BMI, adolescent smoking and drinking, and participant’s parents’ 223 
education. In addition, the models with antenatal CMD symptoms as the exposure were 224 
adjusted for preconception CMD symptoms. Population attributable fractions were 225 
estimated for each level of preconception and antenatal CMD symptoms, using the adjusted 226 
risk ratios. 35  227 
 228 
All analyses included participants who responded in at least one preconception wave and at 229 
least one perinatal wave. Multiple imputation by chained equations was implemented to 230 
handle missing data. 36 Datasets were imputed separately for women and men and for 231 
continuous and binary outcomes. 40 imputations were used according to proportion of 232 
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participants (40%) with missing data on one or more variables. 37 All analysis variables 233 
were included in the imputation models, in addition to an auxiliary variable of divorce or 234 
separation of participant’s parents by the end of wave six, which was predictive of non-235 
response. Estimates were obtained by pooling results using Rubin’s rules. 38 Available case 236 
analyses were also conducted in a sensitivity analysis (see Supplementary Table 1 and 237 
Supplementary Table 2).  238 
 239 
Role of the funding source 240 
 241 
Funding sources had no role in study design, data collection, data analysis, data 242 
interpretation, or writing of the report. The corresponding author had full access to all data 243 
in the study and had responsibility for the final decision to submit for publication. 244 
 245 
Ethics committee approval 246 
 247 
Data collection protocols were approved by the human research ethics committee at the 248 
Royal Children’s Hospital, Melbourne, Australia.  249 
  250 
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Results 251 
 252 
Our sample included 398 women with 609 children and 267 men with 421 children. The 253 
flow of participants through VIHCS is presented in Figure 1. Demographics of those 254 
screened for, identified as eligible for and participating in VIHCS broadly matched those of 255 
the original adolescent cohort (VAHCS). 17  Basic demographics of the sample and 256 
proportion of missing data in each variable are presented in Table 1. Approximately one 257 
half of women and one quarter of men had CMD symptoms in at least one of the adolescent 258 
study waves, with similar proportions seen during the young adult waves; 27% of women 259 
and 11% of men had CMD symptoms persisting across both adolescence and young 260 
adulthood, while 11% of both women and men had symptoms during pregnancy at 32 261 
weeks gestation. Of those with complete birth outcome data, approximately 6% of both 262 
women and men had babies who were either preterm or SGA. 263 
 264 
The unadjusted and adjusted associations between the two exposures of preconception and 265 
antenatal CMD symptoms and birth outcomes for women, using imputed data are shown in 266 
Table 2. There was evidence of an association between antenatal CMD symptoms and PTB, 267 
with maternal symptoms increasing PTB risk (relative risk (RR) 3·5; 95% confidence 268 
interval (CI) 1·3,9·1); this association remained after adjustment for the woman’s parents’ 269 
high school completion, ethnicity, preconception CMD symptoms, overweight or 270 
underweight in adolescence and smoking and binge drinking in adolescence (adjusted RR 271 
4·4; 95% CI 1·4,14·1). Assuming that this estimate reflects the magnitude of the true causal 272 
effect, this increased risk translates to a reduction in PTB by as much as 13% (the 273 
population attributable fraction), had no women experienced antenatal CMD symptoms. 274 
When gestational age at birth was considered as a continuous variable, this effect was in the 275 
same direction. Little evidence was found for an association between preconception or 276 
antenatal CMD symptoms and SGA, as either a binary or continuous outcome.  277 
 278 
In men (Table 3), there was evidence of an association between preconception CMD 279 
symptoms and PTB, with persistent CMD symptoms across adolescence and young 280 
adulthood showing the greatest magnitude (RR 8·8; 95% CI 2·4,32·2). This remained after 281 
adjustment (adjusted RR 7·0; 95% CI 1·8,26·8) and when gestational age at birth was 282 
considered as a continuous variable (unadjusted beta -0·8; 95% CI -1·5,-0·1 and adjusted 283 
beta -0·8; 95% CI -1·5,-0·01), translating to an earlier gestational age of around five days in 284 
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men exposed to persistent preconception CMD symptoms compared with those without 285 
preconception symptoms. The corresponding population attributable fraction is 31%. There 286 
was little evidence of an association between paternal preconception or antenatal CMD 287 
symptoms and SGA and between paternal antenatal CMD symptoms and PTB, when 288 
considered as either a continuous z-score or binary outcome. 289 
 290 
Available case analyses yielded a similar pattern of results for both women and men (see 291 
Supplementary Table 1 and Supplementary Table 2).  292 
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Discussion 293 
 294 
Infants of men with persistent preconception CMD symptoms were more than six times 295 
more likely to be born preterm than infants of men without preconception CMD symptoms. 296 
Similarly, mean gestational age at birth among infants exposed to persistent paternal 297 
preconception CMD symptoms was almost one week earlier than among unexposed infants. 298 
If our estimates reflect the magnitude of the true causal effects, up to 31% of PTBs could be 299 
attributable to processes relating to persistent paternal preconception CMD symptoms. We 300 
also found an increased risk of PTB among infants exposed to maternal antenatal CMD 301 
symptoms, corresponding to a population attributable fraction of 13% of PTBs; these 302 
findings are consistent with earlier reports. 39 However, evidence of an association between 303 
paternal preconception CMD and offspring PTB has not previously been reported. These 304 
paternal associations persisted after adjustment for potential paternal socioeconomic, 305 
substance use, and BMI confounders. Thus this study provides a first indication that men’s 306 
CMD symptoms in the decades prior to conception are associated with offspring PTB: an 307 
early life marker of disease and developmental risk. 308 
 309 
The prevalence of preconception CMD symptoms in our study was similar to that 310 
previously reported in other prospective cohorts. 40,41 Likewise, the prevalence of antenatal 311 
CMD symptoms in women was similar to that of a previous meta-analysis, 42 while the 312 
prevalence of antenatal CMD symptoms observed in men was at the upper end of 313 
previously reported meta-analytic bounds. 43,44 The prevalence of PTB and SGA were also 314 
broadly consistent with Australian population data. 45   315 
 316 
Several mechanisms may explain the association between maternal antenatal CMD 317 
symptoms and offspring PTB. We accounted for a number of background factors and 318 
maternal characteristics that might increase risk of both maternal CMD symptoms and PTB, 319 
including family of origin demographics such as education and ethnicity, substance use, 320 
prior preconception CMD symptoms, and BMI. There remains potential for residual 321 
confounding, including lifetime experience of interpersonal violence or unplanned 322 
pregnancy. 46,47 There are also a number of potential mediators of these associations which 323 
warrant further investigation in larger samples. These include antidepressant use during 324 
pregnancy (although increased risk for PTB has also been found in those with untreated 325 
antenatal depression 39,48), obstetric morbidities of preeclampsia, gestational diabetes, and 326 
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gestational hypertension 49,50 and health risks such as substance use, poor nutrition and 327 
reduced engagement with antenatal care. 2,51  Antenatal CMD symptoms may also lead to 328 
adverse birth outcomes through impacts on maternal endocrine and immune functioning, all 329 
implicated in PTB. 52,53  330 
 331 
We did not find evidence of preconception maternal effects. Prior findings are mixed; those 332 
studies reporting preconception associations have mostly assessed preconception stress 333 
exposure closer to the time of conception 9 so may better reflect antenatal effects. Evidence 334 
in this study for maternal antenatal associations but not maternal preconception or paternal 335 
antenatal, provide some further support for a potential causal effect of stress-related 336 
intrauterine processes. 337 
 338 
There are similarly a range of processes by which paternal preconception CMD symptoms 339 
may be associated with offspring PTB. One possibility is residual confounding by early life 340 
characteristics, such as childhood maltreatment. 54 A further potential explanation is that the 341 
risk from paternal preconception CMD symptoms is mediated through maternal antenatal 342 
factors. Assortative mating is a tendency to choose partners with similar characteristics and 343 
has been observed in couples affected by CMD. 55 Partners of men with CMD are also at 344 
increased risk of exposure to other risk factors for adverse birth outcomes, including 345 
socioeconomic adversity, tobacco smoke exposure, and intimate partner violence. 4,56,57  346 
 347 
Associations between persistent preconception CMD symptoms in men and infant PTB may 348 
also be mediated by paternal processes occurring in the months immediately before 349 
conception. In the testes, the production of new sperm cells from germ cells begins at 350 
puberty and continues throughout life. Production of each sperm cell takes around three 351 
months and is affected by environmental exposures, including substance use, poor nutrition, 352 
and exposure to environmental toxins, which are associated with both paternal CMD and 353 
offspring development. 58 Thus such stressors occurring during the months before 354 
conception may mediate associations between preconception CMD and offspring PTB. 6  355 
 356 
Given the dose-response relationship between preconception CMD symptoms and offspring 357 
PTB, a further possibility is that chronic or recurrent CMD in the preconception years may 358 
have direct, cumulative and enduring effects on the male reproductive tract. There is some 359 
precedent for this proposal in the animal literature, 13 although it has been little examined in 360 
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humans. The pre-puberty period, with the formation of blood-testis and blood-epididymis 361 
barriers and commencement of spermatogenesis, has also been implicated as a sensitive 362 
window during which exposures may have a greater influence on reproductive 363 
development. 59 In our study, strong associations were observed between offspring PTB and 364 
paternal preconception but not antenatal CMD symptoms. These findings raise the 365 
possibility of sensitivity of the male germline to stress, not limited to the immediate 366 
preconception window but beginning in late childhood and extending into adolescence.  367 
 368 
We did not find evidence of an association between preconception or antenatal CMD 369 
symptoms and offspring SGA in either women or men. These findings are consistent with 370 
results of prior meta-analyses. 39,60 One potential contributor is the biological heterogeneity 371 
of SGA, which comprises both constitutional differences attributable to genetic factors and 372 
processes relating to fetal growth restriction. Capturing these subtypes of SGA would 373 
require repeated assessments of fetal growth, beyond this study’s scope. It remains possible 374 
that parental CMD may influence fetal growth restriction.  375 
 376 
Strengths of this study include the repeated assessment of CMD symptoms across 15 years 377 
from adolescence to young adulthood and during subsequent pregnancies. Some limitations 378 
should also be noted. While we attempted to control for baseline confounders associated 379 
with both CMD and adverse birth outcomes, it is also possible that there is some residual 380 
confounding from unmeasured socio-environmental risks such as early life trauma, 381 
interpersonal violence, and socioeconomic adversity. Nonetheless, our finding of different 382 
maternal and paternal associations also suggest that results are not entirely attributable to 383 
familial confounding, under the assumption that maternal and paternal CMD symptoms are 384 
similarly confounded. 16 Infant birth outcomes were assessed by maternal report, which may 385 
be subject to reporting bias, although prior studies have found good agreement between 386 
maternal report and medical records of birthweight and gestational age at birth, particularly 387 
when continuous data are collected and when reported in the postpartum or early childhood. 388 
30,61,62 In our study, most birth outcome data were collected at two months postpartum, with 389 
a smaller proportion collected at one year postpartum (3%) or the following VAHCS wave 390 
(11%, mean child age 3.8 years). This study was limited to infants born when parents were 391 
aged between 29-35 years. This design allowed us to maximise recruitment across the 392 
period of peak fertility in Australia but results may not be generalisable to older or younger 393 
parents with different risk profiles.  394 
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 395 
As with all cohort studies, the possibility of differential recruitment, attrition and non-396 
response, and changing population demographics over time may have led to 397 
underrepresentation of some population groups. VAHCS maintains a high retention rate, 398 
and 85% of those with live births during screening participated in VIHCS. The retained and 399 
participating samples were broadly representative of the baseline VAHCS and eligible 400 
VIHCS samples respectively on measured baseline characteristics, but may differ on 401 
unmeasured confounders. Similarly, we were unable to examine associations within specific 402 
population groups known to have higher rates of preterm births, such as Aboriginal and 403 
Torres Strait Islander peoples 63,64, and this remains an area for future research. The sample 404 
in this study was relatively small, reducing precision of our estimates; findings should be 405 
interpreted as preliminary, and need replication in larger or pooled samples with similarly 406 
strong longitudinal designs. Missing data were low at each preconception and postpartum 407 
wave, but higher antenatally due to challenges of detecting all pregnancies before birth. We 408 
addressed potential biases arising from missing data using multiple imputation and the 409 
conclusions were unaltered. 410 
 411 
Life course epidemiology and public health policy have long been grounded in assumptions 412 
around the causal primacy of maternal exposures and those occurring during pregnancy and 413 
early life. 65 While maternal antenatal risk factors for adverse birth outcomes remain an 414 
important focus for intervention, findings of the current study join a growing body of 415 
evidence highlighting the relevance of both paternal exposures and those prior to  416 
conception for offspring outcomes. 6 Given the high prevalence of CMD and the known 417 
adverse outcomes of PTB, the potential public health impact of their relationship is 418 
substantial. Our findings require replication in larger and diverse samples, with further 419 
examination of the mechanisms by which paternal persistent preconception CMD symptoms 420 
and maternal antenatal CMD symptoms might influence offspring PTB. Whether mediated 421 
by biological or psychosocial processes, our findings support calls for an expansion of 422 
preconception care to include strategies to address CMD, for both men and women. 66 The 423 
findings also underscore the importance of optimising mental health in adolescence and 424 
young adulthood, prior to pregnancy, emphasising the need for investment in coordinated 425 
care between child and adolescent, adult and specialist perinatal mental health services. 67 426 
Intervention in adolescence to prevent onset and persistence of CMD into adulthood and 427 
pregnancy is likely to yield benefits not only for parents’ own continuing mental health, but 428 
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also for the development of their children, either by preventing the potential direct impact of 429 
preconception CMD on offspring birth outcomes or interrupting potentially more complex 430 
developmental risk trajectories. 431 
 432 
  433 
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 665 
n %* Missing (%) n %* Missing (%)
Parents of participant completing high school
Neither parent completed high school 222 36.8 115 27.6
At least one parent completed high school 381 63.2 302 72.4
Ethnicity (three generation European)
Three generation European 526 93.3 366 96.3
Three generation non European 38 6.7 14 3.7
Overweight in any adolescent wave                  
(BMI >25)
Overweight 168 27.8 85 20.4
Not overweight 436 72.2 331 79.6
Underweight in any adolescent wave 
(BMI<18)
Underweight 94 15.6 43 10.3
Not underweight 510 84.4 373 89.7
Binge drinking in any adolescent wave
Binge dinking 191 32.1 212 52.2
No binge drinking 404 67.9 194 47.8
Cigarette smoking six or seven days per 
week in any adolescent wave
Smoking 121 19.9 75 17.8
No smoking 488 80.1 346 82.2
Symptoms of CMD in adolescence and young 
adulthood
None 236 38.9 249 59.3
Adolescent only 126 20.8 61 14.5
Young adult only 82 13.5 65 15.5
Adolescent and young adult 162 26.7 45 10.7
Total number in adolescence 290 47.6 106 25.2
Total number in young adulthood 244 40.1 110 26.1
Symptoms of CMD at 32 weeks gestation
No 371 88.8 281 89.5
Yes 47 11.2 33 10.5
Preterm birth (<37 weeks gestation)
No 565 93.2 330 94.0
Yes 41 6.8 21 6.0
Small for gestational age (< 10th centile)
No 566 94.5 324 94.2
Yes 33 5.5 20 5.8
Gestational age at birth (weeks)**
39.16 
(1.84)
39.19 
(1.96)
Size for gestational age (birthweight z-
scores)**
0.27 
(1.08)
0.20 
(1.00)
*% among those with available data for that variable   **Mean and standard deviation
0 (0%)
3 (0.5%)
191 (31.4%)
3 (0.5%)
10 (1.6%)
1 (0.2%)
0 (0%)
107 (25.4%)
70 (16.6%)
77 (18.3%)
14 (2.3%)
4 (1%)
41 (9.7%)
5 (1.2%)
15 (3.6%)
Infants from women N=609 Infants from men N=421
Table 1: Characteristics of the cohort (N=1030), by sex of parent 
6 (1%)
45 (7.4%)
5 (1.2%)
5 (0.8%)
5 (0.8%)
25 
 
 666 
%**
Unadjusted 
RR
p-
value
Adjusted 
RR*
p-
value
Mean (SD)
Unadjusted 
beta
p-
value
Adjusted 
beta*
p-
value
6.5
39.12 (2.09)
7.2 1.00 (0.33, 3.05) 0.998 0.94 (0.31, 2.89) 0.919 39.23 (1.66) 0.08 (-0.40, 0.55) 0.755 0.09 (-0.38, 0.57) 0.698
8.5 1.55 (0.51, 4.66) 0.437 1.60 (0.53, 4.79) 0.402 39.38 (1.89) 0.13 (-0.48, 0.75) 0.669 0.11 (-0.52, 0.73) 0.737
6.2 1.02 (0.42, 2.49) 0.960 1.04 (0.40, 2.70) 0.931 39.07 (1.64) -0.06 (-0.48, 0.35) 0.764 -0.08 (-0.51, 0.34) 0.697
5.1 39.20 (1.78)
18 3.46 (1.31, 9.14) 0.012 4.42 (1.39, 14.06) 0.012 38.91 (2.15) -0.25 (-0.97, 0.48) 0.507 -0.26 (-1.04, 0.51) 0.503
%**
Unadjusted 
RR
p-
value
Adjsted 
RR*
p-
value
Mean (SD)
Unadjusted 
beta
p-
value
Adjusted 
beta*
p-
value
5 0.29 (1.10)
6.6 1.27 (0.45, 3.61) 0.647 1.34 (0.49, 3.64) 0.572 0.22 (1.04) -0.09 (-0.40, 0.21) 0.547 -0.09 (-0.38, 0.21) 0.569
5.2 0.92 (0.27, 3.19) 0.896 1.17 (0.33, 4.07) 0.811 0.09 (1.10) -0.14 (-0.48, 0.21) 0.435 -0.16 (-0.51, 0.19) 0.371
5.6 1.08 (0.42, 2.76) 0.874 0.96 (0.38, 2.40) 0.925 0.34 (1.07) 0.01 (-0.24, 0.27) 0.922 0.07 (-0.19, 0.32) 0.606
5.2 0.26 (1.08)
7.5 1.45 (0.55, 3.79) 0.452 1.82 (0.67, 4.95) 0.243 0.29 (1.05) -0.01 (-0.29, 0.27) 0.947 -0.07 (-0.37, 0.22) 0.619
Table 2: Associations between preconception and antepartum symptoms of CMD with gestational age and size for gestational age in infants from women (N=609)
Symptoms of CMD in adolescence and 
young adulthood***
Symptoms of CMD at 32 weeks 
gestation****
Small for gestational age (<10th centile) Size for gestational age (birthweight z-scores)
Preterm birth (<37 weeks gestation)
(95% CI) (95% CI)
Gestational age at birth (weeks)
(95% CI) (95% CI)
None 
Adolescent only
Young adulthood only
Both adolescent and young adulthood
No
Imputed models using Poisson or linear regression within a generalised estimating equation framework with robust standard errors *adjusted for parents of participant completing high school, 
ethnicity, overweight, underweight, binge drinking and tobacco smoking in adolescence. Analyses at 32 weeks gestation also adjusted for symptoms of CMD in adolescence and young adulthood. 
**Proportion with outcome for each category of exposure using imputed data. ***Preconception symptoms defined as: adolescent: CIS-R≥12 in any wave 1-6; young adult: CIS-R≥12 in wave 7 
or GHQ-12≥3 in wave 8 or GHQ-12≥3 in wave 9 or CIDI diagnosis at wave 9. ****Antepartum symptoms defined as: EPDS≥10 at 32 weeks gestation.
(95% CI) (95% CI) (95% CI) (95% CI)
None 
Adolescent only
Young adulthood only
Both adolescent and young adulthood
No
Yes
Yes
Symptoms of CMD in adolescence and 
young adulthood***
Symptoms of CMD at 32 weeks 
gestation****
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%**
Unadjusted 
RR
p-
value
Adjusted 
RR*
p-
value
Mean (SD)
Unadjusted 
beta
p-
value
Adjusted 
beta*
p-
value
2 39.40 (1.50)
9.2 4.58 (0.97, 21.74) 0.055 4.28 (0.97, 18.92) 0.055 38.93 (2.73) -0.47 (-1.26, 0.32) 0.246 -0.42 (-1.18, 0.33) 0.273
6.8 3.71 (0.81, 16.94) 0.090 3.71 (0.84, 16.35) 0.083 39.27 (1.93) -0.18 (-0.87, 0.51) 0.608 -0.18 (-0.86, 0.51) 0.611
17.2 8.79 (2.40, 32.17) 0.001 6.97 (1.81, 26.84) 0.005 38.54 (2.32) -0.83 (-1.53, -0.13) 0.020 -0.76 (-1.51, -0.01) 0.048
5.7 39.23 (1.92)
10.5 1.58 (0.34, 7.41) 0.563 1.19 (0.26, 5.41) 0.821 38.67 (2.22) -0.53 (-1.42, 0.36) 0.244 -0.52 (-1.44, 0.39) 0.262
%**
Unadjusted 
RR
p-
value
Adjusted 
RR*
p-
value
Mean (SD)
Unadjusted 
beta
p-
value
Adjusted 
beta*
p-
value
5.1 0.19 (0.93)
9 1.75 (0.55, 5.55) 0.338 1.45 (0.44, 4.72) 0.538 0.15 (1.10) -0.05 (-0.41, 0.32) 0.809 -0.03 (-0.39, 0.33) 0.883
3.9 0.72 (0.11, 4.75) 0.731 0.68 (0.11, 4.34) 0.686 0.39 (0.98) 0.16 (-0.21, 0.53) 0.405 0.16 (-0.21, 0.52) 0.400
9.6 1.81 (0.63, 5.19) 0.269 1.39 (0.46, 4.24) 0.560 0.07 (1.16) -0.06 (-0.44, 0.32) 0.769 -0.02 (-0.39, 0.35) 0.927
6.1 0.18 (1.01)
7.2 1.02 (0.24, 4.33) 0.984 0.96 (0.18, 5.02) 0.960 0.31 (1.03) 0.11 (-0.23, 0.45) 0.532 0.09 (-0.26, 0.44) 0.605
Imputed models using Poisson or linear regression within a generalised estimating equation framework with robust standard errors *adjusted for parents of participant completing high school, 
ethnicity, overweight, underweight, binge drinking and tobacco smoking in adolescence. Analyses at 32 weeks gestation also adjusted for symptoms of CMD in adolescence and young adulthood. 
**Proportion with outcome for each category of exposure. ***Preconception symptoms defined as: adolescent: CIS-R≥12 in any wave 1-6; young adult: CIS-R≥12 in wave 7 or GHQ-12≥3 in wave 
8 or GHQ-12≥3 in wave 9 or CIDI diagnosis at wave 9. ****Antepartum symptoms defined as: GHQ-12≥3  at 32 weeks gestation.
Symptoms of CMD in adolescence and 
young adulthood***
Symptoms of CMD at 32 weeks 
gestation****
Small for gestational age (<10th centile) Size for gestational age (birthweight z-scores)
(95% CI) (95% CI) (95% CI) (95% CI)
None 
Adolescent only
Young adulthood only
Both adolescent and young adulthood
None 
No
Yes
Table 3: Associations between preconception and antepartum symptoms of CMD with gestational age and size for gestational age in infants from men (N=421)
Preterm birth (<37 weeks gestation) Gestational age at birth (weeks)
(95% CI) (95% CI) (95% CI) (95% CI)
No
Yes
Adolescent only
Young adulthood only
Both adolescent and young adulthood
Symptoms of CMD in adolescence and 
young adulthood***
Symptoms of CMD at 32 weeks 
gestation****
